Stocks and Investing Stocks and Investing
Mon, February 28, 2011

SQM, BABY, CWST, MDR, QLTI, ARCC Expected To Be Up After Next Earnings Releases


Published on 2011-02-28 06:20:38 - WOPRAI
  Print publication without navigation


February 28, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, March 1st 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and 12 Consecutive Days earnings reports. QUIMICA Y MINERA CHIL-SP ADR (NYSE:SQM), NATUS MEDICAL INC (NASDAQ:BABY), CASELLA WASTE SYSTEMS INC-A (NASDAQ:CWST), MCDERMOTT INTL INC (NYSE:MDR), QLT INC (NASDAQ:QLTI), ARES CAPITAL CORP (NASDAQ:ARCC) are all expected to be Up After their earnings are released Tuesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Tuesday:

     Symbol     Company                             # of Reports            Quarter     Release Time
     SQM        QUIMICA Y MINERA CHIL-SP ADR        12 Quarter              Q4          After
     BABY       NATUS MEDICAL INC                   12 Quarter              Q4          Before
     CWST       CASELLA WASTE SYSTEMS INC-A         6 Quarter               Q3          After
     MDR        MCDERMOTT INTL INC                  6 Quarter               Q4          After
     QLTI       QLT INC                             12 Quarter              Q4          Before
     ARCC       ARES CAPITAL CORP                   6 Quarter               Q4          Before
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

QUIMICA Y MINERA CHIL-SP ADR (NYSE:SQM) - Chemical and Mining Company of Chile Inc. engages in the production and sale of various fertilizers worldwide. The company provides various specialty plant nutrition products, including sodium nitrate, potassium nitrate, potassium sulfate, and sodium potassium nitrate, which are used on tobacco, coffee, vegetables, sugar cane, and other high-value crops. The company markets its specialty plant nutrition products under the various brands names comprising Ultrasol for application via fertirrigation; Qrop for soil application; Speedfol for foliar application; and Allganic, the family of products designed for organic crops. It also offers iodine for use in various medical, agricultural, and industrial applications, such as X-Ray contrast media, biocides, antiseptics and disinfectants, pharmaceutical, polarizing films for liquid crystal displays, chemicals, and herbicides; and iodine derivatives for use in various medical and industrial applications, as well as in human and animal nutrition products. In addition, the company provides lithium carbonate for use in various applications, including batteries, frits for the ceramic and enamel industries, heat resistant glass, primary aluminum, air conditioning chemicals, continuous casting powder for steel extrusion, pharmaceuticals, and lithium derivatives; lithium hydroxide as a raw material in the lubricating grease, dyes, and battery industries; and lithium metal for use as a catalyst in the pharmaceutical and chemical industries, as well as for the production of aluminum-lithium alloys and lithium primary batteries. Further, it offers various industrial chemicals comprising sodium nitrate, potassium nitrate, boric acid, and potassium chloride, as well as salts for thermo-solar applications. The company was founded in 1968 and is headquartered in Santiago, Chile.

NATUS MEDICAL INC (NASDAQ:BABY) - Natus Medical Incorporated develops, manufactures, and markets neurodiagnostic and newborn care products worldwide. It provides healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The companys product offerings include neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems and phototherapy devices for the treatment of jaundice in newborn; head-cooling products for the treatment of brain injury in newborns; and software systems for managing and tracking disorders and diseases. The companys newborn hearing screening products consist of the ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners, as well as hearing screening supply products that are used with newborn hearing screening devices; diagnostic hearing assessment products comprise the Navigator Pro system, the Scout Sport diagnostic device, the HINT PRO, the AuDX PRO, and the Cochlea-Scan to identify abnormalities affecting the peripheral and central auditory nervous systems; and diagnostic hearing supply products. Natus Medical also offers monitoring systems, balance and mobility products, and jaundice management products. In addition, the company offers medical devices, including photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, and newborn circumstraints; disposable supplies, which include neonatal noise attenuators, phototherapy eye masks, restraining boards, and x-ray shields; and newborn screening data management products. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. The company was founded in 1987 and is headquartered in San Carlos, California.

CASELLA WASTE SYSTEMS INC-A (NASDAQ:CWST) - Casella Waste Systems, Inc. provides solid waste management services consisting of collection, transfer, disposal, and recycling services primarily in the eastern United States. It offers non-hazardous solid waste services, including collection operations, transfer stations, material recycling facilities, and disposal facilities. The company also markets recyclable metals, aluminum, plastics, and paper and corrugated cardboard, which have been processed at its facilities; and recyclables purchased from third parties. In addition, it generates and sells electricity under a contract at a waste-to-energy facility. The company serves residential, commercial, municipal, and industrial customers in Vermont, New Hampshire, New York, Massachusetts, Maine, Connecticut, Pennsylvania, New Jersey, North Carolina, Tennessee, Georgia, Florida, Michigan, and Wisconsin. It has a 50% joint venture with US GreenFiber LLC to manufacture, market, and sell cellulose insulation made from recycled fiber. As of May 31, 2009, the company owned and/or operated 32 solid waste collection operations, 31 transfer stations, 37 recycling facilities, 9 subtitle D landfills, 1 landfill permitted to accept construction and demolition materials, and 1 waste-to-energy facility. Casella Waste Systems, Inc. was founded in 1975 and is headquartered in Rutland, Vermont.

MCDERMOTT INTL INC (NYSE:MDR) - McDermott International, Inc., through its subsidiaries, operates as an engineering and construction company worldwide. It operates in three segments: Offshore Oil and Gas Construction, Government Operations, and Power Generation Systems. The Offshore Oil and Gas Construction segment engages in the front-end design and detailed engineering, fabrication, and installation of offshore drilling and production facilities; and installation of marine pipelines and subsea production systems. It also provides project management and procurement services. In addition, this segment operates a fleet of marine vessels used in offshore construction and various fabrication facilities. The Government Operations segment manufactures and supplies critical nuclear components, fuels, and assemblies for government and commercial uses, as well as provides various services, including uranium processing, environmental site restoration services, and management and operating services for various U.S. Government-owned facilities primarily within the nuclear weapons complex of the U.S. Department of Energy. It also supplies research reactor fuel elements for colleges, universities, and national laboratories; offers uranium-based products used for medical isotopes; and converts or downblends high-enriched uranium into low-enriched fuel for use in commercial reactors to generate electricity, as well as provides heavy fabrications for industrial use, including components for defense applications. The Power Generation Systems segment supplies fossil-fired boilers, commercial nuclear steam generators and components, environmental equipment and components, and related services. It designs, engineers, manufactures, constructs and services utility and industrial power generation systems, including boilers used to generate steam in electric power plants, pulp and paper making, chemical and process applications, and other industrial uses. The company was founded in 1923 and is based in Houston, Texas.

QLT INC (NASDAQ:QLTI) - QLT Inc., a biotechnology company, engages in the development and commercialization of therapies for the eye. It offers Visudyne, a photosensitizer to treat the eye disease, known as wet age related macular degeneration (wet AMD). Visudyne is also used for the treatment of subfoveal CNV due to pathologic myopia, or severe near-sightedness, and presumed ocular histoplasmosis. Its product candidates include punctal plug drug delivery system, a Phase II clinical trial product candidate for the treatment of glaucoma and ocular hypertension; Visudyne combined with Anti-VEGF drugs for the treatment of wet AMD; QLT091001, a Phase Ib clinical trial product candidate, which is an orally administered synthetic retinoid replacement therapy for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle; and QLT091568, a prodrug of a beta adrenergic antagonist for the treatment of glaucoma and ocular hypertension. The company operates primarily in the United States, Europe, Canada, and Japan. QLT Inc. was founded in 1981 and is headquartered in Vancouver, Canada.

ARES CAPITAL CORP (NASDAQ:ARCC) - Ares Capital Corporation is a private equity firm specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The firm will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The firm typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The firm invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The firm also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The firm prefers to be an agent and/or lead the transactions in which it invests. The firm also seeks board representation in its portfolio companies. Ares Capital Corporation was founded in 2004 and is based in New York, New York with additional offices in Los Angeles, California; Chicago, Illinois; and Atlanta, Georgia. The firm operates as a subsidiary of ARES Private Debt Group.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources